|
Madecassic acid
|
|
18449-41-7
|
|
Methylprednisolone acetate
|
|
53-36-1
|
|
1-Dehydro-6-gingerdione
|
|
76060-35-0
|
|
Garcinone C
|
|
76996-27-5
|
|
Muramine
|
|
2292-20-8
|
|
(±)-Vesamicol hydrochloride
|
|
120447-62-3
|
|
PNU159682-EDA
|
|
2255344-14-8
|
|
Varenicline-[d4]
|
|
2183239-01-0
|
|
Hexahydrocurcumin
|
|
36062-05-2
|
|
Puromycin hydrochloride
|
|
3506-23-8
|
|
17-DMAG hydrochloride
|
|
467214-21-7
|
|
Cefsulodin sodium
|
|
52152-93-9
|
|
Cycloastragenol
|
|
78574-94-4
|
|
Ethyl 4-(rhamnosyloxy)benzylcarbamate
|
|
208346-80-9
|
|
Gefitinib-[d6]
|
|
1228664-49-0
|
|
(-)-Syringaresinol
|
|
6216-81-5
|
|
Mulberroside A
|
|
102841-42-9
|
|
6-Sulfatoxy Melatonin-[d4]
|
|
1309935-98-5
|
|
Grasshopper ketone
|
|
41703-38-2
|
|
(D-Ala2,D-Leu5)-Enkephalin Trifluoroacetate
|
|
|
|
Recombinant IGF-I (human)
|
|
67763-96-6
|
|
15-Nonacosanol
|
|
2764-81-0
|
|
Sodium L-glutamate (30% aqueous solution)
|
|
68187-30-4
|
|
Gartanin
|
|
33390-42-0
|
|
Methyl isodrimeninol
|
|
442851-27-6
|
|
(S)-Ibrutinib
|
|
936563-97-2
|
|
7,4'-Di-O-methylapigenin
|
|
5128-44-9
|
|
Milnacipran-[d5] hydrochloride
|
|
|
|
10-Gingerol
|
|
23513-15-7
|
|
p-Anisil
|
|
1226-42-2
|
|
(3R)-Atorvastatin Cyclic Calcuim Salt (Isopropyl) Impurity
|
|
|
|
(S)-3(2h)-Pyridazinone, 6-(4-Aminophenyl)-4,5-Dihydro-5-Methyl-
|
|
101328-84-1
|
|
β-Aspartylaspartic acid TFA salt
|
|
|
|
(1'S,2'S)-Nicotine-1'-Oxide-[d3]
|
|
|
|
(±)-Anabasine
|
|
13078-04-1
|
|
Icariside E5
|
|
126176-79-2
|
|
Rubanthrone A
|
|
441764-20-1
|
|
(S,R,S)-AHPC-PEG1-azide
|
|
2101200-09-1
|
|
Morachalcone A
|
|
76472-88-3
|
|
15-Hydroxy Lubiprostone-[d7]
|
|
1217511-55-1
|
|
Damnacanthal
|
|
477-84-9
|
|
Rauvotetraphylline B
|
|
1422506-50-0
|
|
α-CGRP (human) TFA
|
|
|
|
racemic Tenofovir-[d7]
|
|
|
|
Cassiachromone
|
|
28955-30-8
|
|
Combretastatin A4
|
|
117048-59-6
|
|
(R)-N-Desacryloyl N-3-Propionyl Ibrutinib
|
|
1288338-96-4
|
|
Sitostenone
|
|
1058-61-3
|
|
Ceftriaxone sodium hydrate (2:4:7)
|
|
104376-79-6
|
|
MMAE-[d8]
|
|
2070009-72-0
|
|
6-Hydroxyrubiadin
|
|
87686-86-0
|
|
Xanthoxyletin
|
|
84-99-1
|
|
(-)-Phaseic acid
|
|
24394-14-7
|
|
(R)-(-)-VAPOL hydrogenphosphate
|
|
871130-18-6
|
|
Nuchensin
|
|
25782-24-5
|
|
(Cys(S)2)-Octreotide trifluoroacetate salt
|
|
|
|
Tat-NR2B9c TFA
|
|
1834571-04-8
|
|
Hirsutenone
|
|
41137-87-5
|
|
Dihydromorin
|
|
18422-83-8
|
|
(R)-2-((6-(3-aminopiperidin-1-yl)-3-methyl-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)methyl)benzamide
|
|
1820685-30-0
|
|
(R)-(+)-HA-966
|
|
123931-04-4
|
|
(S)-N1-(2-aminoethyl)-3-(4-ethoxyphenyl)propane-1,2-diamine.3HCl
|
|
221640-06-8
|
|
Haginin A
|
|
74174-29-1
|
|
Diltiazem-[d4] Hydrochloride
|
|
1217769-52-2
|
|
Momordicoside L
|
|
81348-83-6
|
|
Cleomiscosin A
|
|
76948-72-6
|
|
Tafamidis-[d3]
|
|
|
|
Nicarbazin-[d8]
|
|
|
|
Cirsilineol
|
|
41365-32-6
|
|
Methyl rosmarinate
|
|
99353-00-1
|
|
Retatrutide
|
|
2381089-83-2
|
|
Edaravone-[d5]
|
|
1228765-67-0
|
|
(1S,2S)-1-Amino-2-Indanol
|
|
163061-74-3
|
|
Gingerenone A
|
|
128700-97-0
|
|
Hydrangetin
|
|
485-90-5
|
|
α1-Mating Factor TFA salt
|
|
|
|
Flurbiprofen Sodium
|
|
56767-76-1
|
|
Momordicoside K
|
|
81348-84-7
|
|
Tripeptide-10 citrulline acetate
|
|
2763584-34-3
|
|
Esculentic acid
|
|
103974-74-9
|
|
(±)-Dihydrozeatin
|
|
14894-18-9
|
|
(+)-Leucocyanidin
|
|
69256-15-1
|
|
Bonducellin
|
|
83162-84-9
|
|
((2R,7aS)-2-fluorohexahydro-1H-pyrrolizin-7a-yl)methanol
|
|
2097518-76-6
|
|
Osimertinib-[d6]
|
|
1638281-44-3
|
|
BCN-PEG4-NHS ester
|
|
1702356-19-1
|
|
3-Azidopropan-1-ol
|
|
72320-38-8
|
|
PMX 53 TFA
|
|
852629-87-9
|
|
(R)-Metoprolol hydrochloride
|
|
|
|
Sarafloxacin-[d8] hydrochloride hydrate
|
|
|
|
Cyclo(L-Ala-L-Pro)
|
|
36357-32-1
|
|
Bakkenolide B
|
|
18455-98-6
|
|
Trifluoroacetyl Tripeptide-2 TFA
|
|
|
|
Neritaloside
|
|
465-13-4
|
|
Butenafine-[13C,d3] HCl
|
|
|
|
Amifostine Thiol-[d6] Dihydrochloride
|
|
|
|
sGnRH-A TFA
|
|
|
|
Asciminib-[15N,d4]
|
|
|
|
Xanthyletin
|
|
553-19-5
|
|
(R,R)-Empagliflozin Impurity
|
|
2452301-42-5
|